Sign in

CIK 0001372299

  • Non-accelerated filer
  • Smaller reporting company

Ocugen, Inc.

Sign in to watch
Ticker
OCGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 484-328-4701
Business address
11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
Former names
HISTOGENICS CORP
  1. 4 Open-market sale Chief Financial Officer sold 31,000 shares at $8.18 ($253,673)
  2. 4 Open-market sale Senior Vice President sold 15,711 shares at an average $13.68 ($214,954)
  3. 4 Open-market sale Director sold 88,000 shares at an average $15.02 ($1,321,480)
  4. 4 Open-market sale Chief Financial Officer sold 7,990 shares at $10.98 ($87,730)
  5. 4 Open-market sale Director sold 70,000 shares at an average $14.02 ($981,700)
  6. 4 Open-market sale Chief Executive Officer sold 195,809 shares at $14.24 ($2,788,320)
  7. 4 Open-market sale Senior Vice President sold 34,308 shares at an average $11.60 ($397,953)
  8. 4 Open-market sale Director sold 350,000 shares at $11.70 ($4,095,000)
  9. 4 Open-market sale Director sold 7,500 shares at $5.33 ($39,975)
  10. 4 Exercise or conversion Director acquired 28,000 shares (option exercise)
  11. 4 Exercise or conversion Chief Financial Officer acquired 35,591 shares (option exercise)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 15 · 288 filings